Lot-document scope confirmed before quotation · Research use only
  • Specification Review
  • Lot Documents on Request
  • Business Support · Xi’an
  • Destination Eligibility Confirmed
西安诺和达生物科技有限公司
For research, development and manufacturing use only. Not for human or veterinary use.

Cognitive & Neuropeptides · Source-reviewed dossier

DSIP

Source-Reviewed Research Dossier

DSIP stands for delta sleep-inducing peptide. It is a short chain of amino acids, the building blocks of proteins. It was found in the 1970s in blood draining from rabbit brains and was first suggested as a sleep-promoting factor. Later research could not confirm a DSIP gene, a natural precursor protein, or a specific receptor in the body. Its natural role is still unclear. One animal study reported that DSIP and a modified version reduced seizures in rats. Researchers study DSIP to understand neuropeptides, small signaling molecules in the brain. This catalog material is for laboratory research only, not for human use.

Research use only Lot documents on request
DSIP research product family with 3 catalog variants
AI-generated packaging mockup for catalog navigation. It is not a photograph of an actual supplied lot; container, label and presentation may vary.

Product family

Compound overview

Shared values below are consolidated from the current catalog record. They are not independent verification or lot results; request the applicable product specification and ask which lot records are available before ordering.

Product identity

Product type
Peptide research compound
Catalog family
DSIP
Research category
Cognitive & Neuropeptides
Catalog CAS RN
62568-57-4
Catalog molecular formula
C35H48N10O15
Catalog molecular weight
848.81 g/mol
Catalog sequence
Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu
Evidence status
Unresolved endogenous identity and predominantly preclinical evidence
Intended use
Research, development and manufacturing use only

Literature reference parameters

Compound or material class
Delta sleep-inducing nonapeptideCatalog-family identity
Evidence scope
Unresolved endogenous identity and predominantly preclinical evidenceDo not generalize beyond the cited model
Source review
Primary or authoritative records linked belowChecked 2026-09-01

Identity safeguard Reference identifiers above describe the literature compound record. Confirm the supplied form, formula, molecular weight, purity and storage conditions against the applicable product specification and any available lot records.

Mechanism of action

How DSIP is studied

A target-to-pathway view grounded in the linked research records.

The sleep hypothesis

The name DSIP comes from early animal experiments suggesting it promoted deep, slow-wave sleep. Over time, that idea did not hold up. A 2006 review found that some sleep-promoting effects came from artificial versions of DSIP, not from DSIP itself. No clear natural sleep pathway was confirmed. The sleep link remains an open question, not a proven effect.

Missing basic biology

For most signaling molecules, researchers can identify the gene that makes them, the protein they come from, and the receptor they act on, such as a small gland near the brain. For DSIP, none of these have been confirmed. This gap makes it hard to say what DSIP does naturally. It also means its name should not be treated as proof of a sleep benefit.

Seizure findings in rats

In one rat study, a chemical trigger caused seizures. DSIP and a modified version were given, and both were linked to fewer, less severe, and shorter seizures, plus changes in brain wave patterns. The modified version seemed stronger in that model. This is animal evidence from a specific seizure test, not proof that DSIP prevents seizures in people.

Evidence scope and limits

The available research includes one rat seizure study and one critical review. There are no human trials of DSIP as a finished medicine. Effects seen in rats cannot be assumed to apply to people for sleep, mood, or seizures. This catalog material is a research chemical with a defined identity, not a verified treatment.

Reported research findings

What published studies report about DSIP

Reported outcomes are paired with their experimental model and evidence boundary.

Critical review

DSIP biology remains unresolved

A 2006 review concluded that fundamental questions about DSIP identity and physiological function remained unsettled.

The uncertainty argues against definitive sleep or treatment claims.

Read the primary study
Rat study

Antiepileptic activity was reported in an experimental model

A 2005 study evaluated DSIP and an analogue in metaphit-provoked seizures in rats.

A seizure model does not establish human sleep efficacy.

Read the primary study
Translation boundary: findings are limited to the evidence level stated on each card. Experimental protocol quantities are research details, not usage instructions.

Catalog options

Variant specifications

Pack-level catalog data; lot-level controls remain document-specific.

Catalog no.DS2
Pack size2 mg × 10 vials
Specification & documents for DS2

Product specification

Single-component peptide · 2 mg/vial nominal · 10-vial pack · supplied form and release limits controlled by lot specification.

Lot documentation

Document availability and scope must be confirmed for this variant and lot in the written quotation. A catalog description is not a lot-specific test result.

Catalog no.DS5
Pack size5 mg × 10 vials
Specification & documents for DS5

Product specification

Single-component peptide · 5 mg/vial nominal · 10-vial pack · supplied form and release limits controlled by lot specification.

Lot documentation

Document availability and scope must be confirmed for this variant and lot in the written quotation. A catalog description is not a lot-specific test result.

Catalog no.DS10
Pack size10 mg × 10 vials
Specification & documents for DS10

Product specification

Single-component peptide · 10 mg/vial nominal · 10-vial pack · supplied form and release limits controlled by lot specification.

Lot documentation

Document availability and scope must be confirmed for this variant and lot in the written quotation. A catalog description is not a lot-specific test result.

Quality system

Quality documentation

A listed document is not proof of availability for this lot. Ask the team to confirm the current COA status and the scope of any other records before ordering.

Lot-specific Certificate of AnalysisAvailability and scope must be confirmed for the selected catalog variant and lot
COA availability unconfirmed Ask about availability
Product Specification SheetAvailability and scope must be confirmed for the selected catalog variant and lot
Confirm before ordering Request
Analytical Method SummaryAvailability and scope must be confirmed for the selected catalog variant and lot
Confirm before ordering Request

Analytical interpretation

Interpret the documents, not just the headline number.

Use the source-reviewed guide to separate chromatographic area purity, quantitative assay, LC-MS identity, composition and stability evidence before comparing variants or requesting a lot record.

Open the Quality & Documentation Hub

HPLC area ≠ assayA dominant peak does not establish target mass fraction.

Intact mass ≠ full sequenceIdentity strength depends on resolution and orthogonal evidence.

Counterions affect contentWater, salt form and solvents change the as-is composition.

Storage needs a data basisShipping practice is not the same as stability evidence.

Evidence map

Research context

Published studies and regulatory records, not customer testimonials or usage guidance.

Critical review

DSIP biology remains unresolved

The uncertainty argues against definitive sleep or treatment claims.

View primary record
Rat study

Antiepileptic activity was reported in an experimental model

A seizure model does not establish human sleep efficacy.

View primary record
Evidence boundary: each card states its evidence type. Human trials and regulatory records describe the studied or regulated intervention; preclinical records remain model-specific. None verifies the identity, quality, safety or efficacy of this catalog lot or provides usage instructions.

Literature basis

Curated references

Third-party publications selected for direct relevance.

  1. 01

    Delta sleep-inducing peptide: a still unresolved riddle

    Graf MV, Kastin AJ. Peptides. 2006. PMID 16539679.

    Critical review
  2. 02

    Antiepileptic activity of DSIP and its analogue in rats

    Preclinical study. 2005. PMID 15911358.

    Rat study

Research FAQ

DSIP questions

Concise answers for researchers comparing identity, evidence and catalog variants.

What effects are studied for DSIP?

In a rat seizure model, DSIP and a modified version reduced how often, how severe, and how long seizures lasted after a chemical trigger. A separate review found that DSIP's natural identity, receptor, and sleep role remain unresolved. So the supported effects are limited to that animal model and do not extend to humans.

How should the DSIP research findings be understood?

The available research includes one rat seizure study and one critical review. There are no human trials of DSIP as a finished medicine. Effects seen in rats cannot be assumed to apply to people for sleep, mood, or seizures. This catalog material is a research chemical with a defined identity, not a verified treatment.

What evidence is available for DSIP?

The evidence is old, heterogeneous and largely preclinical, with substantial mechanistic uncertainty.

Does the cited research validate this catalog material?

No. The cited records describe their own intervention, formulation, model and controls. They do not verify the identity, purity, sterility, safety or efficacy of a catalog lot.

Which quality documents can be requested?

A lot-specific COA, product specification sheet and analytical method summary can be requested where applicable.

How should DSIP be stored?

Store at -20 °C, protected from light and moisture. After reconstitution, aliquot and avoid repeated freeze-thaw cycles. Confirm the applicable storage statement on the product-specific specification and lot documentation.

Knowledge center

Related insights

Owned educational content connected to this family.

DSIP editorial illustration

DSIP and Sleep: Why the Evidence Remains Unresolved

Delta sleep-inducing peptide has a memorable name, but the literature does not support treating that name as a settled mechanism or a proven human…

Updated October 1, 2026

Knowledge tools

Continue with structured evidence

Move from this dossier into canonical evidence maps, verified status records, analytical interpretation and laboratory calculations.

Internal technical source review

Claims were checked against the linked primary publication, regulatory label or authoritative compound record. Published findings stay attached to their study model, formulation and route. Catalog identity and lot quality remain controlled by the applicable specification and lot-specific documents.

Editorial status: NHD evidence editorial workflow · 2026-09-01 · Not independent medical review · Review policy

Technical procurement

Ready to request a quote?

Selected: DS2 · 2 mg × 10 vials